Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

2,194 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Imatinib and beyond--exploring the full potential of targeted therapy for CML.
Quintás-Cardama A, Kantarjian H, Cortes J. Quintás-Cardama A, et al. Nat Rev Clin Oncol. 2009 Sep;6(9):535-43. doi: 10.1038/nrclinonc.2009.112. Epub 2009 Aug 4. Nat Rev Clin Oncol. 2009. PMID: 19652654 Review.
Identification of a complex formed between nuclear proteins and the transcriptional enhancer of interferon-inducible genes that is present in the peripheral blood myeloid cells of CML but not normal individuals.
Seong DC, Gottlieb K, Suh SP, Sims S, Talpaz M, Kantarjian H, Deisseroth A. Seong DC, et al. J Interferon Res. 1992 Oct;12(5):323-7. doi: 10.1089/jir.1992.12.323. J Interferon Res. 1992. PMID: 1431311
Detection of minimal residual disease by polymerase chain reaction of bcr/abl transcripts in chronic myelogenous leukaemia following allogeneic bone marrow transplantation.
Lee M, Khouri I, Champlin R, Kantarjian H, Talpaz M, Trujillo J, Freireich E, Deisseroth A, Stass S. Lee M, et al. Br J Haematol. 1992 Dec;82(4):708-14. doi: 10.1111/j.1365-2141.1992.tb06948.x. Br J Haematol. 1992. PMID: 1482658
Treatment of advanced stages of Philadelphia chromosome-positive chronic myelogenous leukemia with interferon-alpha and low-dose cytarabine.
Kantarjian HM, Keating MJ, Estey EH, O'Brien S, Pierce S, Beran M, Koller C, Feldman E, Talpaz M. Kantarjian HM, et al. J Clin Oncol. 1992 May;10(5):772-8. doi: 10.1200/JCO.1992.10.5.772. J Clin Oncol. 1992. PMID: 1569449
2,194 results
Jump to page
Feedback